🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate pharmacokinetics (PK), pharmacodynamics (PD) and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-23
Trial ID
NCT02000804
Treatments Being Tested
Subjects will receive their first dose of darapladib in the clinical resear...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05
Trial ID
NCT00704431
Treatments Being Tested
The primary objective of this study is to examine the effects of SB-480848 ...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-08-26
Trial ID
NCT00734032
The purpose of this study is to compare the effects of SB-480848 with place...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08
Trial ID
NCT00368576
Treatments Being Tested
The overall objective of this integrated analysis is to evaluate the clinic...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01636271
Treatments Being Tested
This study will determine the effect of single and repeat administration of...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-19
Trial ID
NCT01873339
Treatments Being Tested
AIM III is a prospective, randomized, double-blinded, placebo controlled tr...
Status
Completed
Location
Mayo Clinic
Start Date
2010-02-04
Trial ID
NCT01067339
Treatments Being Tested
The purpose of this study is to characterize the systemic and ocular safety...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02
Trial ID
NCT01506895
Treatments Being Tested
The purpose of this study is to determine any differences in pharmacokineti...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01154114
Treatments Being Tested
This will be an exploratory, open-label, single sequence, two part study (P...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-26
Trial ID
NCT02058641
Treatments Being Tested